Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre … A Jorsal, C Kistorp, P Holmager, RS Tougaard, R Nielsen, A Hänselmann, ... European journal of heart failure 19 (1), 69-77, 2017 | 427 | 2017 |
Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study JJ Rasmussen, C Selmer, PB Østergren, KB Pedersen, M Schou, ... PloS one 11 (8), e0161208, 2016 | 168 | 2016 |
Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma? JJ Rasmussen, M Schou, PL Madsen, C Selmer, ML Johansen, P Hovind, ... Journal of hypertension 36 (2), 277-285, 2018 | 75 | 2018 |
Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids JJ Rasmussen, M Schou, PL Madsen, C Selmer, ML Johansen, ... American heart journal 203, 49-56, 2018 | 58 | 2018 |
Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids JJ Rasmussen, M Schou, C Selmer, ML Johansen, F Gustafsson, ... Clinical endocrinology 87 (3), 249-256, 2017 | 55 | 2017 |
Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis M Paquette, D Gauthier, A Chamberland, A Prat, EDL Rolfe, ... Clinical biochemistry 77, 20-25, 2020 | 36 | 2020 |
Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation M Refsgaard Holm, H Christensen, J Rasmussen, ML Johansen, M Schou, ... ESC Heart Failure 6 (5), 983-991, 2019 | 28 | 2019 |
Procoagulant state in current and former anabolic androgenic steroid abusers S Chang, JJ Rasmussen, MN Frandsen, M Schou, ML Johansen, J Faber, ... Thrombosis and Haemostasis 118 (04), 647-653, 2018 | 26 | 2018 |
Iron deficiency: prevalence and relation to cardiovascular biomarkers in heart failure outpatients M Schou, H Bosselmann, F Gaborit, K Iversen, JP Goetze, G Soletomas, ... International journal of cardiology 195, 143-148, 2015 | 25 | 2015 |
The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 … R Nielsen, A Jorsal, RS Tougaard, JJ Rasmussen, M Schou, L Videbæk, ... Diabetes, Obesity and Metabolism 22 (11), 2141-2150, 2020 | 21 | 2020 |
Endogenous testosterone levels are associated with risk of type 2 diabetes in women without established comorbidity JJ Rasmussen, C Selmer, S Frøssing, M Schou, J Faber, ... Journal of the Endocrine Society 4 (6), bvaa050, 2020 | 21 | 2020 |
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity … JB Rasmussen, JD Knudsen, M Arpi, HC Schønheyder, T Benfield, ... Journal of Antimicrobial Chemotherapy 69 (2), 506-514, 2014 | 21 | 2014 |
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: data from the … NH Brandt-Jacobsen, ML Johansen, J Rasmussen, JL Forman, MR Holm, ... Diabetes & metabolism 47 (4), 101190, 2021 | 19 | 2021 |
Random blood glucose may be used to assess long‐term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting JB Rasmussen, LS Nordin, NS Rasmussen, JA Thomsen, LA Street, ... Tropical Medicine & International Health 19 (12), 1515-1519, 2014 | 19 | 2014 |
Comparable Outcomes of Short-Course and Prolonged-Course Therapy in Selected Cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Pooled … L Thorlacius-Ussing, H Sandholdt, J Nissen, J Rasmussen, R Skov, ... Clinical Infectious Diseases 73 (5), 866-872, 2021 | 18 | 2021 |
Mineralocorticoid receptor antagonist improves cardiac structure in type 2 diabetes: data from the MIRAD trial NH Brandt-Jacobsen, P Lav Madsen, ML Johansen, JJ Rasmussen, ... Heart Failure 9 (8), 550-558, 2021 | 18 | 2021 |
An abductive inference approach to assess the performance-enhancing effects of drugs included on the World Anti-Doping Agency prohibited list A Breenfeldt Andersen, GA Jacobson, J Bejder, D Premilovac, ... Sports Medicine 51 (7), 1353-1376, 2021 | 18 | 2021 |
Serum insulin-like factor 3 levels are reduced in former androgen users, suggesting impaired Leydig cell capacity JJ Rasmussen, J Albrethsen, MN Frandsen, N Jørgensen, A Juul, ... The Journal of Clinical Endocrinology & Metabolism 106 (7), e2664-e2672, 2021 | 18 | 2021 |
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled … ML Johansen, M Schou, P Rossignol, MR Holm, J Rasmussen, N Brandt, ... Diabetes, Obesity and Metabolism 21 (10), 2305-2314, 2019 | 18 | 2019 |
Hemoglobin levels and blood pressure are associated in rural black africans JB Rasmussen, DL Mwaniki, LU Kaduka, MK Boit, K Borch‐Johnsen, ... American Journal of Human Biology 28 (1), 145-148, 2016 | 16 | 2016 |